Published in J Biol Chem on February 18, 2000
TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest (2000) 5.78
Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest (2003) 3.14
Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med (2002) 2.98
Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest (2002) 2.85
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev (2007) 2.82
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest (2003) 2.79
Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A (2001) 2.56
Osteoimmunology: interactions of the bone and immune system. Endocr Rev (2008) 2.32
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med (2005) 2.21
Disorders of bone remodeling. Annu Rev Pathol (2011) 2.05
TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J. J Exp Med (2012) 1.99
Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr (2010) 1.87
Current developments in salivary diagnostics. Biomark Med (2010) 1.83
Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med (2009) 1.81
Acid phosphatases. Mol Pathol (2002) 1.55
Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res Ther (2011) 1.51
Role of NF-κB in the skeleton. Cell Res (2010) 1.45
Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res Ther (2007) 1.37
Role of RANKL and RANK in bone loss and arthritis. Ann Rheum Dis (2002) 1.35
The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol (2007) 1.32
Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis (2004) 1.25
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. Am J Pathol (2004) 1.24
Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors. Arthritis Res Ther (2010) 1.24
Interaction of staphylococci with bone. Int J Med Microbiol (2009) 1.23
Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia. J Cell Biol (2004) 1.19
A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. J Clin Invest (2006) 1.15
Mechanisms balancing skeletal matrix synthesis and degradation. Biochem J (2002) 1.12
Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production. Infect Immun (2007) 1.12
IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J Immunol (2011) 1.08
The role of TNF-receptor family members and other TRAF-dependent receptors in bone resorption. Arthritis Res (2000) 1.07
Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo. Infect Immun (2005) 1.05
Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Ann Rheum Dis (2003) 1.04
Inactivation of membrane tumor necrosis factor alpha by gingipains from Porphyromonas gingivalis. Infect Immun (2005) 1.01
Cytokine-mediated bone destruction in rheumatoid arthritis. J Immunol Res (2014) 1.01
Receptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis. J Biol Chem (2010) 1.00
Osteoporosis and gastrointestinal disease. Gastroenterol Hepatol (N Y) (2010) 0.99
Rheumatoid arthritis and salivary biomarkers of periodontal disease. J Clin Periodontol (2010) 0.98
T Cell Migration in Rheumatoid Arthritis. Front Immunol (2015) 0.98
Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Biochem Med (Zagreb) (2013) 0.97
Osteoclasts: New Insights. Bone Res (2013) 0.97
Immunological reaction in TNF-α-mediated osteoclast formation and bone resorption in vitro and in vivo. Clin Dev Immunol (2013) 0.96
The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis. Thyroid (2011) 0.95
IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor. PLoS One (2006) 0.95
Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis. J Biol Chem (2012) 0.94
AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression. Gene Ther (2008) 0.93
Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. Expert Opin Ther Targets (2010) 0.92
Immune regulation of bone loss by Th17 cells. Arthritis Res Ther (2008) 0.90
Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis. J Biol Chem (2010) 0.90
P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption. PLoS One (2011) 0.89
Suppressive effects of 1,4-dihydroxy-2-naphthoic acid administration on bone resorption. Osteoporos Int (2009) 0.89
Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis. Arthritis Res (2001) 0.88
Regulation of sealing ring formation by L-plastin and cortactin in osteoclasts. J Biol Chem (2010) 0.88
Osteoclasts-Key Players in Skeletal Health and Disease. Microbiol Spectr (2016) 0.88
Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. J Assoc Res Otolaryngol (2009) 0.86
NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging. Vet Comp Oncol (2008) 0.85
Effect of cytokines on osteoclast formation and bone resorption during mechanical force loading of the periodontal membrane. ScientificWorldJournal (2014) 0.85
Stimulation of osteoclast formation by inflammatory synovial fluid. Virchows Arch (2006) 0.85
Molecular biology of bone remodelling. Clin Cases Miner Bone Metab (2008) 0.84
Cell-cell interaction promotes rat marrow stromal cell differentiation into endothelial cell via activation of TACE/TNF-alpha signaling. Cell Transplant (2009) 0.84
Rutin inhibits osteoclast formation by decreasing reactive oxygen species and TNF-alpha by inhibiting activation of NF-kappaB. Exp Mol Med (2008) 0.84
B cells promote obesity-associated periodontitis and oral pathogen-associated inflammation. J Leukoc Biol (2014) 0.84
The emerging role of Interleukin 27 in inflammatory arthritis and bone destruction. Cytokine Growth Factor Rev (2012) 0.83
Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation. Bone (2009) 0.83
Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it. J Bone Miner Res (2014) 0.83
Circulating monocytes: an appropriate model for bone-related study. Osteoporos Int (2015) 0.83
Brucella abortus invasion of osteoblasts inhibits bone formation. Infect Immun (2012) 0.82
A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activation. PLoS One (2013) 0.82
Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis. Rheumatol Int (2011) 0.81
Alteration of newly induced endochondral bone formation in adult mice without tumour necrosis factor receptor 1. Clin Exp Immunol (2005) 0.81
Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade. Arthritis Rheumatol (2016) 0.81
Bone remodeling at microscrew interface near extraction site in the beagle dog mandible-histologic and immunohistochemical analyses. J Appl Oral Sci (2013) 0.81
Anti-TNF in rheumatoid arthritis: an overview. Wien Med Wochenschr (2015) 0.80
Diet-Induced Obesity and Its Differential Impact on Periodontal Bone Loss. J Dent Res (2015) 0.80
Lactobacillus reuteri 6475 Increases Bone Density in Intact Females Only under an Inflammatory Setting. PLoS One (2016) 0.80
Strontium-doped calcium phosphate and hydroxyapatite granules promote different inflammatory and bone remodelling responses in normal and ovariectomised rats. PLoS One (2013) 0.79
SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss. J Bone Miner Res (2014) 0.79
The effect of Astragalus extractive on alveolar bone rebuilding progress of tooth extracted socket of ovariectomied rats. Afr J Tradit Complement Altern Med (2014) 0.79
Regulation of SFRP-1 expression in the rat dental follicle. Connect Tissue Res (2012) 0.79
Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia. Front Immunol (2016) 0.79
Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications. Adipocyte (2014) 0.78
Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. Infect Immun (2015) 0.78
Interleukin-7 and interleukin-15 for cancer. J Cancer (2014) 0.78
Pathway analysis of microRNA expression profile during murine osteoclastogenesis. PLoS One (2014) 0.78
R848, a toll-like receptor 7 agonist, inhibits osteoclast differentiation but not survival or bone-resorbing function of mature osteoclasts. Cytotechnology (2012) 0.77
Osteoclast-related cytokines from biopsy specimens predict mandibular invasion by oral squamous cell carcinoma. Exp Ther Med (2010) 0.77
Evolution of caspase-mediated cell death and differentiation: twins separated at birth. Cell Death Differ (2017) 0.76
A review of UHMWPE wear-induced osteolysis: the role for early detection of the immune response. Bone Res (2016) 0.76
Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells. J Immunol Res (2015) 0.76
The tumor necrosis factor type 2 receptor plays a protective role in tumor necrosis factor-α-induced bone resorption lacunae on mouse calvariae. J Bone Miner Metab (2011) 0.76
Epigallocatechin-3-gallate protects against tumor necrosis factor alpha induced inhibition of osteogenesis of mesenchymal stem cells. Exp Biol Med (Maywood) (2016) 0.76
Dietary zinc deficiency induces oxidative stress and promotes tumor necrosis factor-α- and interleukin-1β-induced RANKL expression in rat bone. J Clin Biochem Nutr (2016) 0.76
NF-kappaB2 (p100) limits TNF-alpha-induced osteoclastogenesis. J Clin Invest (2009) 0.76
A pathogenic trace of Tannerella forsythia - shedding of soluble fully active tumor necrosis factor α from the macrophage surface by karilysin. Mol Oral Microbiol (2014) 0.76
Involvement of dendritic cells in autoimmune diseases in children. Pediatr Rheumatol Online J (2007) 0.75
Rocaglamide-A Potentiates Osteoblast Differentiation by Inhibiting NF-κB Signaling. Mol Cells (2015) 0.75
TNF-α Promoter Polymorphisms Predict the Response to Etanercept More Powerfully than that to Infliximab/Adalimumab in Spondyloarthritis. Sci Rep (2016) 0.75
STING regulates abnormal bone formation induced by deficiency of DNase II. Arthritis Rheumatol (2016) 0.75
IL-12 Inhibits Lipopolysaccharide Stimulated Osteoclastogenesis in Mice. J Immunol Res (2015) 0.75
RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis. Arthritis Rheumatol (2016) 0.75
Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis. J Immunol (2016) 0.75
TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest (2000) 5.78
Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res (1999) 4.68
Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res (2000) 3.47
A critical role of lambda 5 protein in B cell development. Cell (1992) 3.09
Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation (1996) 2.79
Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol (2001) 2.49
A new murine model of accelerated senescence. Mech Ageing Dev (1981) 2.40
Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. EMBO J (1991) 2.25
The proteins encoded by the VpreB and lambda 5 pre-B cell-specific genes can associate with each other and with mu heavy chain. J Exp Med (1990) 2.22
Organization of the murine Ig-related lambda 5 gene transcribed selectively in pre-B lymphocytes. EMBO J (1987) 1.97
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (1995) 1.92
Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun (1985) 1.91
The gamete fusion process is defective in eggs of Cd9-deficient mice. Nat Genet (2000) 1.91
Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science (1992) 1.90
Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem (1994) 1.70
The surrogate light chain in B-cell development. Immunol Today (1993) 1.64
Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation (1995) 1.51
Brain metastasis of Merkel cell carcinoma. Case report and review of the literature. Neurosurg Rev (1999) 1.51
Clinical features of 22 cases with "inter-sterno-costo-clavicular ossification". A new rheumatic syndrome. Arch Orthop Trauma Surg (1979) 1.49
Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun (1990) 1.44
Efficacy of a new hemostatic device, Adapty , after transradial coronary angiography and intervention. J Invasive Cardiol (2000) 1.38
Grading score system: a method for evaluation of the degree of senescence in senescence accelerated mouse (SAM). Mech Ageing Dev (1984) 1.36
Induction of immunoglobulin gene expression in mouse fibroblasts by cycloheximide treatment. J Exp Med (1984) 1.31
Simulation of intracellular Ca2+ oscillation in a sympathetic neurone. J Theor Biol (1981) 1.30
Trans-acting nuclear protein responsible for induction of rearranged human immunoglobulin heavy chain gene. Cell (1986) 1.28
Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis (2001) 1.28
Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension (1999) 1.23
The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol (2008) 1.22
Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol (1994) 1.22
Anatomic variations of the radial artery in patients undergoing transradial coronary intervention. Catheter Cardiovasc Interv (2000) 1.21
A cloned human immunoglobulin heavy chain gene with a novel direct-repeat sequence in 5' flanking region. Gene (1985) 1.20
Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation (1999) 1.20
A new human diploid cell strain, TIG-1, for the research on cellular aging. Exp Gerontol (1980) 1.18
Targeted disruption of cadherin-11 leads to a reduction in bone density in calvaria and long bone metaphyses. J Bone Miner Res (2001) 1.16
Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett (2001) 1.16
Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem Biophys Res Commun (2001) 1.14
Systemic senile amyloid in senescence-accelerated mice. A unique fibril protein demonstrated in tissues from various organs by the unlabeled immunoperoxidase method. Lab Invest (1983) 1.14
Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography. Oncology (2010) 1.14
The transition of cadherin expression in osteoblast differentiation from mesenchymal cells: consistent expression of cadherin-11 in osteoblast lineage. J Bone Miner Res (2001) 1.13
Spontaneous age-associated amyloidosis in senescence-accelerated mouse (SAM). Mech Ageing Dev (1982) 1.13
Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen. Cancer Res (1987) 1.11
Structural features in heparin that interact with VEGF165 and modulate its biological activity. Glycobiology (1999) 1.09
Cataract and other ophthalmic lesions in senescence accelerated mouse (SAM). Morphology and incidence of senescence associated ophthalmic changes in mice. Exp Eye Res (1984) 1.08
Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg (1995) 1.08
Isolation and characterization of senile amyloid--related antigenic substance (SASSAM) from mouse serum. Apo SASSAM is a low molecular weight apoprotein of high density lipoprotein. J Exp Med (1983) 1.07
The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases. Kidney Int (2006) 1.06
Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis (2001) 1.06
B cell development in mice with a defective lambda 5 gene. Eur J Immunol (1993) 1.06
Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury. J Leukoc Biol (2001) 1.06
Reduction of nitric oxide producing activity associated with in vitro aging in cultured human umbilical vein endothelial cell. Biochem Biophys Res Commun (1993) 1.04
Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. Growth Factors (1996) 1.03
Ploidy of human embryonic fibroblasts during in vitro aging. J Gerontol (1982) 1.02
Purification and characterization of a senile amyloid-related antigenic substance (apoSASSAM) from mouse serum. apoSASSAM is an apoA-II apolipoprotein of mouse high density lipoproteins. J Biol Chem (1986) 1.02
Structure and pre-B lymphocyte restricted expression of the VpreB in humans and conservation of its structure in other mammalian species. EMBO J (1988) 1.02
Cell-type-specific and regulated expression of a human gamma 1 heavy-chain immunoglobulin gene in transgenic mice. Proc Natl Acad Sci U S A (1986) 1.02
Two pathways of B-lymphocyte development in mouse bone marrow and the roles of surrogate L chain in this development. Immunol Rev (1994) 1.02
Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Int J Cancer (1992) 1.02
Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus. Kidney Int (1999) 1.01
Nosocomial meningitis due to Campylobacter fetus subsp. fetus in a neonatal intensive care unit. Eur J Pediatr (1988) 1.00
Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis. Am J Pathol (1999) 1.00
Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells. Hepatology (1999) 1.00
Inhibition of eukaryotic DNA polymerase alpha with a novel lysophosphatidic acid (PHYLPA) isolated from myxoamoebae of Physarum polycephalum. J Biol Chem (1992) 1.00
Functional association of CD9 with the Fc gamma receptors in macrophages. J Immunol (2001) 1.00
Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival. Am J Surg Pathol (1993) 0.99
A pre-B- and B cell-specific DNA-binding protein, EBB-1, which binds to the promoter of the VpreB1 gene. Eur J Immunol (1992) 0.99
Tetrahedral magnetic order and the metal-insulator transition in the pyrochlore lattice of Cd2Os2O7. Phys Rev Lett (2012) 0.99
Circulating endothelial cells in Kawasaki disease. Clin Exp Immunol (2003) 0.99
Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest (1992) 0.99
Various factors associated with the manifestation of influenza-like illness. Int J Epidemiol (1992) 0.98
Expression and characterization of murine osteoblast-specific factor 2 (OSF-2) in a baculovirus expression system. Protein Expr Purif (1995) 0.98
Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumatol (2009) 0.97
Isolation of mouse and human cDNA clones encoding a protein expressed specifically in osteoblasts and brain tissues. Biochem Biophys Res Commun (1990) 0.97
Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Ther (1996) 0.97
Structure of extrachromosomal circular DNAs excised from T-cell antigen receptor alpha and delta-chain loci. J Mol Biol (1988) 0.97
Excision products of immunoglobulin gene rearrangements. Immunol Lett (1989) 0.96
Participation of a dominant cytotoxic T cell population defined by a monoclonal antibody in syngeneic anti-tumor responses. Eur J Immunol (1990) 0.96
Quantitative comparison of anti-fading mounting media for confocal laser scanning microscopy. J Histochem Cytochem (2001) 0.95
Gestational age determination, variation of conception date, and external fetal development of sika deer (Cervus nippon yesoensis Heude, 1884) in eastern Hokkaido. J Vet Med Sci (1996) 0.95
Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer (1992) 0.95
A novel human gene that is preferentially transcribed in heart muscle. Gene (1994) 0.94
Cellular stages and molecular steps of murine B-cell development. Cold Spring Harb Symp Quant Biol (1989) 0.94
Time-dependent changes of collagen cross-links and their precursors in the culture of osteogenic cells. Calcif Tissue Int (1992) 0.94
A regulatory factor, Fil1p, involved in derepression of the isocitrate lyase gene in Saccharomyces cerevisiae--a possible mitochondrial protein necessary for protein synthesis in mitochondria. Eur J Biochem (1998) 0.93
Expression and function of the splice variant of the human cadherin-11 gene in subordination to intact cadherin-11. J Bone Miner Res (1999) 0.93
Immunohistochemical localization of androgen receptor in mouse testicular germ cells during fetal and postnatal development. Anat Rec (1996) 0.93
Conserved V(D)J junctional sequence of cross-reactive cytotoxic T cell receptor idiotype and the effect of a single amino acid substitution. Eur J Immunol (1991) 0.93
Blood transfusion, alcohol consumption, and cigarette smoking in causation of hepatocellular carcinoma: a case-control study in Fukuoka, Japan. Jpn J Cancer Res (1988) 0.92
Aging of chick embryo fibroblasts in vitro. III. Polyploid cell accumulation. Exp Cell Res (1979) 0.92
Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells. Biochem Biophys Res Commun (1990) 0.92
Delayed apoptosis of circulating neutrophils in Kawasaki disease. Clin Exp Immunol (2001) 0.92